The Australia pharmacy retail market size reached USD 38.64 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 63.69 Billion by 2033, exhibiting a growth rate (CAGR) of 5.71% during 2025-2033. Key factors driving the market include an aging population with increasing chronic disease prevalence, government healthcare initiatives, digital transformation through e-pharmacy platforms, expanded pharmacist roles, and growing consumer demand for convenient and accessible healthcare services.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024 |
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024 | USD 38.64 Billion |
Market Forecast in 2033 | USD 63.69 Billion |
Market Growth Rate 2025-2033 | 5.71% |
Rising Prevalence of Chronic Diseases and an Aging Population
One of the strongest drivers behind the Australian pharmacy retail market is the growing prevalence of chronic diseases, particularly among the aging population. As the Australian Bureau of Statistics points out, the nation is witnessing a demographic shift, with persons aged 65 years and older expected to account for almost 20% of the overall population by 2030. This population trend is coupled with the rising prevalence of age-related chronic illnesses like diabetes, cardiovascular disease, arthritis, and respiratory illnesses. The propelling demand for ongoing treatment and medication compliance for these conditions is fueling prescription drug, medical supply, and routine health consultation demand, all of which are largely accessed through pharmacies. Pharmacy retailers are reacting by moving beyond the standard dispensing function to offer medication management programs, home delivery, telepharmacy services, and chronic care counseling. The Pharmaceutical Benefits Scheme (PBS) operated by the Australian government also guarantees subsidized access to necessary medicines so that a larger population can meet the cost of continuous treatment. Pharmacies are thus critical points of health access, particularly in rural and disadvantaged areas.
Expansion of Digital Health and E-Pharmacy Platforms
Another factor driving the market is the high rate of development and up-take of digital health products and solutions as well as e-commerce platforms is yet another significant factor driving expansion in the pharmacy retail market in Australia. There has been a noticeable change in consumer behavior in the Australian market as a result of high internet penetration, smartphone adoption, and affinity for convenient and contactless services, a process accelerated by the COVID-19 pandemic. Customers are extensively shopping online at pharmacy websites for prescription drugs, over-the-counter medicines, supplements, and wellness products. This has driven investments towards developing advanced e-pharmacy platforms that provide one-stop-shop integrated services such as online consultations, digital prescriptions, automatic refill reminders, and tracking of delivery. Startups as well as old pharmacy chains have started innovating to offer glitch-free digital consumer experiences, complemented by high-quality supply chain and logistics infrastructures. The regulatory reforms introduced, for instance, the acceptance of electronic prescriptions in all the states and territories, have complemented this transition to digital.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the region/country level for 2025-2033. Our report has categorized the market based on market structure, product type, therapeutic area, drug type, and pharmacy location.
Market Structure Insights:
The report has provided a detailed breakup and analysis of the market based on the market structure. This includes unorganized and organized.
Product Type Insights:
A detailed breakup and analysis of the market based on the product type have also been provided in the report. This includes over-the-counter products, prescribed drugs, non-pharmaceutical products, and medical equipment.
Therapeutic Area Insights:
The report has provided a detailed breakup and analysis of the market based on the therapeutic area. This includes cardiovascular, pain relief/analgesics, vitamins/minerals/nutrients, anti-infective, anti-diabetic, and others.
Drug Type Insights:
A detailed breakup and analysis of the market based on the drug type have also been provided in the report. This includes generic and patented.
Pharmacy Location Insights:
A detailed breakup and analysis of the market based on the pharmacy location have also been provided in the report. This includes street/mall based and hospital based.
Regional Insights:
The report has also provided a comprehensive analysis of all the major regional markets, which include Australia Capital Territory & New South Wales, Victoria & Tasmania, Queensland, Northern Territory & Southern Australia, and Western Australia.
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Scope of the Report |
Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
|
Market Structures Covered | Unorganized, Organized |
Product Types Covered | Over-the-Counter Products, Prescribed Drugs, Non-Pharmaceutical Products, Medical Equipment |
Therapeutic Areas Covered | Cardiovascular, Pain Relief/Analgesics, Vitamins/Minerals/Nutrients, Anti-Infective, Anti-Diabetic, Others |
Drug Types Covered | Generic, Patented |
Pharmacy Locations Covered | Street/Mall Based, Hospital Based |
Regions Covered | Australia Capital Territory & New South Wales, Victoria & Tasmania, Queensland, Northern Territory & Southern Australia, Western Australia |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
Key Benefits for Stakeholders: